Xerox Corporation (NYSE:XRX)

Xerox is the world’s leading enterprise for business process and document management. Its technology, expertise and services enable workplaces – from small businesses to large global enterprises – to simplify the way work gets done so they operate more effectively and focus more on what matters most: their real business. Headquartered in Norwalk, Conn., Xerox offers business process outsourcing and IT outsourcing services, including data processing, healthcare solutions, HR benefits management, finance support, transportation solutions, and customer relationship management services for commercial and government organizations worldwide. The company also provides extensive leading-edge document technology, services, software and genuine Xerox supplies for graphic communication and office printing environments of any size.

Xerox Corporation (NYSE:XRX)’s Financial Overview

Xerox Corporation (NYSE:XRX) declined -0.42% yesterday to close its trading session at $9.46. The company has 1 year Price Target of $11. Xerox Corporation has 52-Week high of $11.39 and 52-Week Low of $8.48. The stock touched its 52-Week High on Apr 19, 2016 and 52-Week Low on Jan 20, 2016. The stock traded with the volume of 6.49 Million shares yesterday. The firm shows the market capitalization of $9.59 Billion.

Xerox Corporation (NYSE:XRX) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.27/share against the analyst consensus estimate of $0.27/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.

The firm is trading with SMA20 of 0.03 Percent, SMA50 of -2.18 Percent and SMA200 of -3.23 percent. Xerox Corporation has P/S value of 0.55 while its P/B value stands at 1.04. Similarly, the company has Return on Assets of 2.5 percent, Return on Equity of 6.7 percent and Return on Investment of 3.7 Percent. The company shows Gross Margin and Operating Margin of 31.6 percent and 4.4 percent respectively.

Many brokerage firms are involved in issuing their ratings on Xerox Corporation (NYSE:XRX). On 7-Nov-16 Morgan Stanley Downgrade Xerox Corporation Stock  to Underweight. Another firm also rated the stock on 13-Sep-16 where SunTrust Initiated the stock to Buy.

The Stock currently has Analyst’ mean Recommendation of 2.9 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 12 analysts offering 12-month price forecasts for Xerox have a median target of 11.00, with a high estimate of 13.00 and a low estimate of 9.50. The median estimate represents a +16.28% increase from the last price of 9.46.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

AstraZeneca PLC (NYSE:AZN)

AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.

AstraZeneca PLC (NYSE:AZN)’s Financial Outlook

The 32 analysts offering 12-month price forecasts for AstraZeneca have a median target of 33.85, with a high estimate of 41.68 and a low estimate of 24.31. The median estimate represents a +26.74% increase from the last price of 26.71.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, AstraZeneca PLC has a Consensus Recommendation of 2. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -0.07% and closed its last trading session at $26.71. The company has the market capitalization of $67.58 Billion. The stock has 52-week high of $35.04 and 52-Week low of $25.88. The firm touched its 52-Week high on Aug 5, 2016 and 52-Week low on Nov 23, 2016. The company has volume of 6.37 Million shares. The company has a total of 2.53 Billion shares outstanding.

AstraZeneca PLC (NYSE:AZN) in the last quarter reported its actual EPS of $0.66/share where the analyst estimated EPS was $0.74/share. The difference between the actual and Estimated EPS is $-0.08. This shows a surprise factor of -10.8 percent.

The company has YTD performance of -17.69 percent. Beta for AstraZeneca PLC stands at 0.75 while its ATR (average true range) is 0.57. The company has Weekly Volatility of 1.70%% and Monthly Volatility of 1.53%%.

AstraZeneca PLC has distance from 20-day Simple Moving Average (SMA20) of -3.14%, Distance from 50-Day Simple Moving Average of -11.37 percent and Distance from 200-Day Simple Moving Average of -10.94%.

The Company currently has ROA (Return on Assets) of 3.9 percent, Return on Equity (ROE) of 16.5 Percent and Return on Investment (ROI) of 11.5% with Gross margin of 82.7 percent and Operating & Profit margin of 14.5% and 10.4% respectively.

 

SHARE